HDAC9 and glioblastoma: Three specific HDAC inhibitor drugs, vorinostat, romidepsin and valproic acid (an anticonvulsant drug with HDAC inhibitory effects) have been tested in clinical trials for GBM with many additional agents being investigated in preclinical studies[184,185].